Oncodona

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

down_arrow
 

Oncodona

Early risk detection of hereditary breast and ovarian cancer.

icon-01.svg

 

 The presence of mutations in BRCA1 or BRCA2 genes are 20-fold higher in women with precocious breast cancer diagnosed before age 40.

icon-01.svg

 

Mutations in BRCA1 and BRCA2 account for approximately 5% of all breast cancers and between 10-15% of ovarian cancers.

icon-01.svg

 

Oncodona test offers genetic counselling by experts

icon-01.svg

 

Oncodona analyzes a panel of 21 genes.

Advanced Reproductive Genetic Services

Overview

It is the most advanced genetic test for early identification of predisposition to inherited cancer. Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.

Who should use Oncodona test?

Who should use Oncodona test?

Oncodona is a simple and complete test for all women who want to have the maximum information about their personal risk of developing cancer.

  • Women diagnosed with breast cancer along with negative genetic screening of BRCA1 and BRCA2.
  • Women with a family member diagnosed with breast and ovarian cancer.
  • Women of general population without known increased risk.
Benefits

Benefits

  • The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
  • A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.
Watch Now

How it works

How it works

Time of delivery of results: 35 days.

Downloads & publications

Brochure

Brochure

Step by Step Patient

Step by Step Patient

 

Success stories

“The genetic counselor was warm, knowledgeable and consistently accessible."

Read more stories

Do you want to start using our Genetic Services?

For further assistance please contact our customer support team by phone or e-mail

Contact us

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

Newsletter subscription